Transcranial magnetic stimulation (TMS) to slow down cognitive decline in Alzheimer*s disease (AD): TMSLA - a monocentric randomized controlled trial.

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2025
This article has no abstract
Epistemonikos ID: 6e57bd2ec6f074e529e782d8c84e1d8e33c86dae
First added on: Apr 11, 2025